Alpha Zero’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$832K Buy
719
+159
+28% +$188K 0.27% 50
2026
Q2
$655K Buy
560
+80
+17% +$81.7K 0.25% 52
2026
Q1
$441K Buy
480
+24
+5% +$24.3K 0.22% 52
2025
Q4
$490K Sell
456
-63
-12% -$60.2K 0.27% 42
2025
Q3
$396K Buy
519
+106
+26% +$78.9K 0.23% 45
2025
Q2
$322K Buy
413
+35
+9% +$27.2K 0.21% 48
2025
Q1
$312K Sell
378
-33
-8% -$27.5K 0.24% 46
2024
Q4
$317K Buy
+411
New +$340K 0.24% 52

Other funds holding LLY

Alpha Zero's LLY Position: Q3 2026 in Review

Alpha Zero increased its Eli Lilly (LLY) stake by 28% in Q3 2026, buying an estimated $188K and bringing the position to 719 shares worth $832K. The position accounts for 0.27% of the portfolio, ranked #50.

Alpha Zero first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 3,945 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Alpha Zero held 719 shares of Eli Lilly worth $832K as of Q3 2026.
  • Alpha Zero bought 159 Eli Lilly shares in Q3 2026, an estimated $188K.
  • Eli Lilly made up 0.27% of Alpha Zero's portfolio in Q3 2026, its #50 holding.
  • Alpha Zero first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 3,945 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Alpha Zero's 13F filing for Q3 2026, filed 6 Nov 2026.